• Alnylam expanded a strategic partnership with Komodo Health to scale the Marmot analytics AI platform across key enterprise functions.
• Marmot will be deployed across Alnylam’s customer-facing organization to support unified, enterprise-wide data-driven decision-making.
• Collaboration began in August 2025, initially focused on custom AI agents for commercial workflows.
• Alnylam integrated enterprise datasets into Marmot, cutting reporting cycles from months to hours.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606250900BIZWIRE_USPR_____20260625_BW007024) on June 25, 2026, and is solely responsible for the information contained therein.